Prolonged QT interval with rivastigmine

descriptionPublicationkeyboard_double_arrow_right Article 01 May 2002 English Publisher:Royal College of PsychiatristsJournal:British Journal of Psychiatry, volume 180, pages 466-466 (issn: 0007-1250, eissn: 1472-1465,

Copyright policy )

Authors: E. Walsh; J. Dourish;

doi: 10.1192/bjp.180.5.466-a

Prolonged QT interval with rivastigmine

- Summary
- Metrics

Abstract

Rivastigmine is an acetylcholinesterase inhibitor licensed in the UK since 1998 for the treatment of mild to moderate Alzheimer's disease. Prolonged QT interval in association with this drug has not been previously described in the literature. A 78-year-old man with dementia was commenced on

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	22
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%